Mark Gaffney
Directeur Général chez Oxular Ltd.
Postes actifs de Mark Gaffney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 11/09/2023 | - |
| Directeur Général | 11/09/2023 | - |
Historique de carrière de Mark Gaffney
Anciens postes connus de Mark Gaffney
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Virtual Software Systems, Inc.
 Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Directeur/Membre du Conseil | 01/03/2016 | 01/09/2017 |
Vedere Bio II, Inc.
 Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Directeur des opérations | - | - |
Formation de Mark Gaffney
| University of Pennsylvania | Undergraduate Degree |
| Boston University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Royaume-Uni | 2 |
| Belgique | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Technology Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Virtual Software Systems, Inc.
Virtual Software Systems, Inc. Packaged SoftwareTechnology Services Virtual Software Systems, Inc. develops a software platform to provide protection for data and applications running in public, private, and hybrid clouds on bare metal or embedded systems. The company was founded in 2014 and is headquartered in Burlington, MA. | Technology Services |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Vedere Bio II, Inc.
Vedere Bio II, Inc. Miscellaneous Commercial ServicesCommercial Services Vedere Bio II, Inc. develops ocular gene therapy. The company is based in Cambridge, MA. The company was founded by Cyrus D. Mozayeni. Cyrus D. Mozayeni has been the CEO since incorporation. | Commercial Services |
- Bourse
- Insiders
- Mark Gaffney
- Expérience
